Your browser is no longer supported. Please, upgrade your browser.
Settings
OHRP OHR Pharmaceutical, Inc. daily Stock Chart
OHRP [NASD]
OHR Pharmaceutical, Inc.
Index- P/E- EPS (ttm)-3.17 Insider Own8.89% Shs Outstand2.90M Perf Week45.68%
Market Cap15.63M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.58M Perf Month59.00%
Income-8.90M PEG- EPS next Q- Inst Own15.70% Short Float8.20% Perf Quarter132.33%
Sales- P/S- EPS this Y55.90% Inst Trans- Short Ratio1.54 Perf Half Y113.89%
Book/sh3.18 P/B1.69 EPS next Y- ROA-71.50% Target Price- Perf Year24.08%
Cash/sh0.72 P/C7.44 EPS next 5Y- ROE-75.80% 52W Range1.58 - 6.28 Perf YTD213.37%
Dividend- P/FCF- EPS past 5Y4.90% ROI- 52W High-14.17% Beta0.87
Dividend %- Quick Ratio3.70 Sales past 5Y- Gross Margin- 52W Low240.71% ATR0.53
Employees3 Current Ratio3.70 Sales Q/Q- Oper. Margin- RSI (14)78.14 Volatility25.64% 13.58%
OptionableYes Debt/Eq0.00 EPS Q/Q47.80% Profit Margin- Rel Volume14.07 Prev Close5.39
ShortableNo LT Debt/Eq0.00 EarningsAug 14 BMO Payout- Avg Volume137.08K Price5.39
Recom- SMA2044.33% SMA5066.25% SMA20079.00% Volume0 Change0.00%
Jan-05-18Downgrade ROTH Capital Buy → Neutral
Nov-27-17Initiated ROTH Capital Buy $7
Oct-27-16Initiated H.C. Wainwright Buy $10
Jun-16-16Resumed ROTH Capital Buy $13
Aug-07-15Reiterated Brean Capital Buy $34 → $30
Mar-30-15Reiterated Chardan Capital Markets Neutral $8 → $3
Mar-27-15Downgrade Chardan Capital Markets Buy → Neutral $20 → $8
Feb-26-15Initiated ROTH Capital Buy $30
Feb-02-15Initiated Chardan Capital Markets Buy $20
Jun-24-14Reiterated Brean Capital Buy $21 → $34
Jul-12-19 09:28AM  NeuBase Therapeutics Closes Merger Transaction with Ohr Pharmaceutical GlobeNewswire +30.19%
Jul-10-19 01:03PM  Ohr Pharmaceutical, Inc. Announces Stockholder Approval of Merger Agreement with NeuBase Therapeutics, Inc. GlobeNewswire +15.18%
Jul-03-19 10:00AM  Ohr Pharmaceutical Urges Stockholders to Vote FOR Merger with NeuBase Therapeutics at Special Meeting on July 10, 2019 GlobeNewswire
May-16-19 08:00AM  NeuBase Therapeutics Designates Industry Leaders to Board of Directors GlobeNewswire
May-15-19 04:01PM  Ohr Pharmaceutical Reports Financial Results for the Fiscal Second Quarter of 2019 GlobeNewswire
Apr-09-19 11:00PM  Rigrodsky & Long, P.A. Files Class Action Suit Against Ohr Pharmaceutical, Inc. GlobeNewswire
Mar-11-19 07:00AM  NeuBase Therapeutics Announces Agreements for $9 Million Financing GlobeNewswire -9.88%
Mar-06-19 02:45PM  Four Tech Stocks To Watch on Wednesday ACCESSWIRE +42.86%
Feb-21-19 10:45AM  Ohr Pharmaceutical Regains Compliance with NASDAQ Listing Requirements GlobeNewswire
Feb-14-19 04:05PM  Ohr Pharmaceutical Reports Financial Results for the Fiscal First Quarter of 2019 GlobeNewswire
01:47PM  Lifshitz & Miller LLP Announces Investigation of CAS Medical Systems, Inc., Entegra Financial Corp., Fidelity Southern Corporation, First Data Corporation, Kinderhook Bank Corp., Maxwell Technologies, Inc., Ohr Pharmaceutical, Inc., and Owens Realty Mortgage, Inc. PR Newswire
Feb-11-19 05:47PM  OHR PHARMACEUTICAL INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Ohr Pharmaceutical, Inc. - OHRP Business Wire +7.48%
Jan-24-19 07:45AM  The Daily Biotech Pulse: Partial Clinical Hold On Advaxis Cervical Cancer Drug, Ohr's Reverse Split, Ironwood Starts Phase 1 Trial Benzinga -6.75%
Jan-23-19 04:30PM  Ohr Pharmaceutical Announces Reverse Stock Split to be Effective February 4, 2019 GlobeNewswire
Jan-13-19 07:55PM  INVESTOR ALERT: Monteverde & Associates PC is Investigating the Recently Announced Merger PR Newswire
Jan-09-19 03:45PM  SHAREHOLDER ALERT: WeissLaw LLP Investigates Ohr Pharmaceutical, Inc. PR Newswire
Jan-08-19 11:07AM  OHR PHARMACEUTICAL INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Merger of Ohr Pharmaceutical, Inc. - OHRP PR Newswire -9.33%
Jan-07-19 03:27PM  OHR PHARMACEUTICAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation of Merger Business Wire -6.19%
Jan-04-19 06:56PM  Bragar Eagel & Squire, P.C. is Investigating the Board of Directors of OHR Pharmaceutical, Inc. (OHRP) on Behalf of Stockholders and Encourages OHRP Investors to Contact the Firm GlobeNewswire -9.92%
02:01PM  Here's more about what could be Pittsburgh's next public company American City Business Journals
12:20PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation Regarding Whether the Sale of Ohr Pharmaceutical, Inc. to NeuBase Therapeutics, Inc. is Fair to Shareholders GlobeNewswire
07:40AM  LifeX Announces Portfolio Company NeuBase Therapeutics To Merge with Ohr Pharmaceutical PR Newswire
Jan-03-19 08:35AM  4 Healthcare Stocks Gaining Speed on Thursday (1/3/19) ACCESSWIRE +61.36%
06:30AM  Ohr Pharmaceutical, Inc. Announces Merger Agreement with NeuBase Therapeutics, Inc. GlobeNewswire
Nov-19-18 07:20AM  Investor Expectations to Drive Momentum within Ocean Bio-Chem, Gaming Partners International, Pershing Gold, OHA Investment, Ohr Pharmaceuticals, and J. W. Mays Discovering Underlying Factors of Influence GlobeNewswire
Aug-14-18 04:05PM  Ohr Pharmaceutical Reports Fiscal Third Quarter 2018 Financial Results GlobeNewswire
Jul-13-18 07:40AM  Complimentary Technical Snapshots on OHR Pharma and Three More Biotech Stocks ACCESSWIRE
Jun-12-18 08:05AM  Breakfast Technical Briefing on Omeros and Three Other Additional Biotech Stocks ACCESSWIRE +50.12%
Jun-04-18 02:40PM  OHR PHARMACEUTICAL, INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors in Ohr Pharmaceutical, Inc.'s Public Offerings To Contact The Firm PR Newswire
May-15-18 04:05PM  Ohr Pharmaceutical Reports Fiscal Second Quarter 2018 Financial Results GlobeNewswire
May-01-18 02:15PM  MAY 7 DEADLINE: Levi & Korsinsky, LLP Notifies Shareholders of an Expanded Lead Plaintiff Deadline in its Action to Recover Losses Suffered by Ohr Pharmaceutical, Inc. Investors ACCESSWIRE
Apr-09-18 03:05PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint to Recover Losses Suffered by Ohr Pharmaceutical, Inc. Investors and Sets a Lead Plaintiff Deadline of April 16, 2018 -- OHRP ACCESSWIRE +6.41%
11:23AM  FINAL DEADLINE ALERT: Brower Piven Reminds Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) To Contact The Firm GlobeNewswire
Apr-05-18 06:00PM  The Klein Law Firm Reminds Investors of Commencement of a Class Action Filed on Behalf of Ohr Pharmaceutical, Inc. Shareholders and a Lead Plaintiff Deadline of April 16, 2018 Business Wire
03:50PM  OHR LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Ohr Pharmaceutical, Inc. To Contact The Firm PR Newswire
Mar-26-18 05:17PM  OHRP EQUITY ALERT: The Law Offices of Vincent Wong Reminds Investors of a Class Action Involving Ohr Pharmaceutical, Inc. and a Lead Plaintiff Deadline of April 16, 2018 Business Wire
03:54PM  OHR LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 In Ohr Pharmaceutical, Inc. To Contact The Firm GlobeNewswire
Mar-20-18 03:55PM  EQUITY ALERT: Levi & Korsinsky, LLP Reminds Shareholders It Filed a Complaint to Recover Losses Suffered by Ohr Pharmaceutical, Inc. Investors and Sets a Lead Plaintiff Deadline of April 16, 2018 Business Wire
03:09PM  Lifshitz & Miller LLP Announces Investigation of BioScrip, Inc., Civitas Solutions, Inc., Iridex Corp., OHR Pharmaceutical, Inc., Overstock.com, Inc., Syneos Health, Inc., Ubiquiti Networks, Inc. and WageWorks, Inc. PR Newswire
Mar-19-18 04:04PM  The Klein Law Firm Announces Commencement of a Class Action Filed on Behalf of Ohr Pharmaceutical, Inc. Shareholders and a Lead Plaintiff Deadline of April 16, 2018 (OHRP) Business Wire
Mar-16-18 03:50PM  DEADLINE ALERT: Brower Piven Reminds Investors of Upcoming Deadline in Class Action Lawsuit and Encourages Shareholders Who Have Losses in Excess of $100,000 from Investment in Ohr Pharmaceutical, Inc. to Contact the Firm Business Wire
Mar-13-18 07:32AM  Innovate Biopharmaceuticals appoints June Almenoff, M.D., Ph.D. as Chief Operating Officer and Chief Medical Officer GlobeNewswire
Mar-08-18 06:04PM  The Klein Law Firm Announces a Class Action Filed on Behalf of Ohr Pharmaceutical, Inc. Shareholders and a Lead Plaintiff Deadline of April 16, 2018 (OHRP) GlobeNewswire -5.46%
05:42PM  OHR INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In OHR Pharmaceutical, Inc. To Contact The Firm Business Wire
Mar-07-18 04:18PM  OHRP INVESTOR ALERT: The Law Offices of Vincent Wong Notifies Investors of a Class Action Involving Ohr Pharmaceutical, Inc. and a Lead Plaintiff Deadline of April 16, 2018 Business Wire +7.16%
03:47PM  SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Ohr Pharmaceutical, Inc. (Nasdaq:OHRP) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit GlobeNewswire
Mar-01-18 05:32PM  OHRP SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Ohr Pharmaceutical, Inc. and a Lead Plaintiff Deadline of April 16, 2018 GlobeNewswire -8.92%
04:46PM  OHR INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In OHR Pharmaceutical, Inc. To Contact The Firm ACCESSWIRE
Feb-28-18 02:45PM  INVESTOR ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint to Recover Losses Suffered by Ohr Pharmaceutical, Inc. Investors and Sets a Lead Plaintiff Deadline of April 16, 2018 Business Wire
Feb-27-18 05:52PM  INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Ohr Pharmaceutical, Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit Business Wire
Feb-23-18 02:00PM  The Klein Law Firm Reminds Investors of an Investigation Regarding Possible Violations of Federal Securities Laws by Ohr Pharmaceutical, Inc. Business Wire
Feb-22-18 06:43PM  OHR INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing in OHR Pharmaceutical, Inc. to Contact the Firm Business Wire
Feb-20-18 02:52PM  The Klein Law Firm Notifies Investors of an Investigation Concerning Possible Violations of Federal Securities Laws by Ohr Pharmaceutical, Inc. (OHRP) Business Wire
Feb-16-18 06:49PM  Robbins Arroyo LLP: Ohr Pharmaceutical, Inc. (OHRP) Misled Shareholders According to a Recently Filed Class Action Business Wire
06:03PM  OHR INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 Investing In OHR Pharmaceutical, Inc. To Contact The Firm PR Newswire
12:23PM  OHRP INVESTOR ALERT: The Law Offices of Vincent Wong Reminds Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Ohr Pharmaceutical, Inc. Business Wire
Feb-15-18 04:30PM  SHAREHOLDER ALERT: Brower Piven Notifies Investors of Class Action Lawsuit And Encourages Those Who Have Losses In Excess Of $100,000 From Investment In Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) To Contact Brower Piven Before The Lead Plaintiff Deadline GlobeNewswire -15.06%
02:40PM  OHRP SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of an Investigation Involving Possible Securities Fraud Violations by the Board of Directors of Ohr Pharmaceutical, Inc. Business Wire
01:58PM  Federman & Sherwood Announces Filing of Securities Class Action Lawsuit Against Ohr Pharmaceutical, Inc. GlobeNewswire
Feb-14-18 07:00PM  Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Ohr Pharmaceutical, Inc. (OHRP) GlobeNewswire
04:05PM  Ohr Pharmaceutical Reports Fiscal First Quarter 2018 Financial Results GlobeNewswire
03:22PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders It Filed a Complaint to Recover Losses Suffered by Ohr Pharmaceutical, Inc. Investors and Sets a Lead Plaintiff Deadline of April 16, 2018 -- OHRP GlobeNewswire
Feb-12-18 08:26AM  Who Are The Major Shareholders Of OHR Pharmaceutical Inc (NASDAQ:OHRP)? Simply Wall St. +6.50%
Jan-19-18 07:45PM  Interested In Healthcare? Why OHR Pharmaceutical Inc (NASDAQ:OHRP) May Be The Entry Point Simply Wall St.
Jan-05-18 09:17AM  Heres Why OHR Pharmaceutical Inc (OHRP) Shares Are Collapsing 80% Today SmarterAnalyst -81.34%
08:51AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga
06:00AM  Ohr Pharmaceutical Announces Efficacy Results from the MAKO Study in Wet-AMD GlobeNewswire
Dec-21-17 07:00AM  Free Research Report as Tesaros Revenue Rocketed 740% ACCESSWIRE
Dec-15-17 07:00AM  Ohr Pharmaceutical Reports Fiscal Year 2017 Financial Results GlobeNewswire -7.60%
Dec-12-17 08:00AM  Ohr Pharmaceutical to Announce Fiscal Fourth Quarter & Year End 2017 Results on Friday, December 15 GlobeNewswire -7.79%
Dec-04-17 08:10AM  Todays Research Reports on Stocks to Watch: Omeros Corporation and Ohr Pharmaceutical ACCESSWIRE +10.16%
Dec-01-17 03:04PM  Heres Why OHR Pharmaceutical Inc (OHRP) Shares Jumped Today SmarterAnalyst +50.59%
Oct-11-17 08:00AM  Ohr Pharmaceutical to Present at the Dawson James 3rd Annual Small Cap Growth Conference GlobeNewswire
Sep-14-17 08:19PM  What Is Ohr Pharmaceutical Incs (OHRP) Share Price Doing? Simply Wall St.
Sep-11-17 04:55PM  SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Ohr Pharmaceutical, Inc. Business Wire
Aug-24-17 09:45AM  Top Ranked Momentum Stocks to Buy for August 24th Zacks
Aug-18-17 08:25AM  TherapeuticsMD (TXMD) Catches Eye: Stock Moves 5.9% Higher Zacks +6.65%
Aug-08-17 04:01PM  Ohr Pharmaceutical Announces Fiscal Third Quarter 2017 Earnings GlobeNewswire
12:10PM  Investor Network: Ohr Pharmaceutical Inc to Host Earnings Call ACCESSWIRE
Jul-31-17 08:00AM  Ohr Pharmaceutical to Announce Fiscal Third Quarter 2017 Results on August 8 GlobeNewswire
Jun-12-17 08:00AM  Ohr Pharmaceutical to Present at the 2017 Marcum Microcap Conference GlobeNewswire
May-11-17 04:15PM  Ohr Pharmaceutical Announces Appointment of Hon. Mike Ferguson as Chairman of the Board of Directors GlobeNewswire
04:01PM  Ohr Pharmaceutical Announces Fiscal Second Quarter 2017 Earnings GlobeNewswire
12:05PM  Investor Network: Ohr Pharmaceutical Inc to Host Earnings Call Accesswire
May-09-17 08:00AM  Ohr Pharmaceutical to Announce Fiscal Second Quarter 2017 Results on May 11 GlobeNewswire
Apr-18-17 08:35AM  Ohr Pharmaceutical (OHRP) Jumps: Stock Adds 15% in Session Zacks
Apr-11-17 06:09PM  Ohr Pharmaceutical Provides Update on Squalamine Study Zacks
Apr-10-17 04:15PM  Ohr Pharmaceutical Provides Update on Ongoing Squalamine Clinical Trial in Wet-AMD GlobeNewswire
04:01PM  Ohr Pharmaceutical Announces Closing of Public Offering of Common Stock and Warrants GlobeNewswire
Apr-05-17 09:23AM  Ohr Pharmaceutical Announces Pricing of $14.175 Million Public Offering of Common Stock and Warrants GlobeNewswire
09:23AM  Ohr Pharmaceutical Announces Pricing of $14.175 Million Public Offering of Common Stock and Warrants
Apr-04-17 04:01PM  Ohr Pharmaceutical Announces Proposed Public Offering of Common Stock and Warrants GlobeNewswire
04:01PM  Ohr Pharmaceutical Announces Proposed Public Offering of Common Stock and Warrants
Mar-02-17 09:39AM  Ohr Pharmaceutical to Present at the Cowen & Company 37th Annual Health Care Conference GlobeNewswire
Feb-22-17 05:26PM  OHR PHARMACEUTICAL INC Files SEC form 8-K, Other Events
Feb-17-17 01:04PM  OHR PHARMACEUTICAL INC Financials
Feb-15-17 03:40PM  The Market Has Got Its Interpretation Of The OHR Pharmaceutical Inc (OHRP) Announcement Wrong Insider Monkey
03:40PM  The Market Has Got Its Interpretation Of The OHR Pharmaceutical Inc (OHRP) Announcement Wrong at Insider Monkey
11:32AM  Ohr Pharmaceutical Reports 4Q Loss, Suspends Trial Investopedia
11:32AM  Ohr Pharmaceutical Reports 4Q Loss, Suspends Trial at Investopedia
OHR Pharmaceutical, Inc. operates as a development stage pharmaceutical company. The company intends to merge with NeuBase Therapeutics, Inc. that focuses on advancing NeuBase's peptide-nucleic acid antisense oligonucleotide technology platform for the development of therapies to address severe and currently untreatable diseases caused by genetic mutations. OHR Pharmaceutical, Inc. is headquartered in New York, New York.